These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16945804)

  • 1. Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.
    Vernooy K; Sicouri S; Dumaine R; Hong K; Oliva A; Burashnikov E; Timmermans C; Delhaas T; Crijns HJ; Antzelevitch C; Rodriguez LM; Brugada R
    Heart Rhythm; 2006 Sep; 3(9):1074-8. PubMed ID: 16945804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brugada syndrome: clinical, electrophysiologic and genetic aspects.
    Gussak I; Antzelevitch C; Bjerregaard P; Towbin JA; Chaitman BR
    J Am Coll Cardiol; 1999 Jan; 33(1):5-15. PubMed ID: 9935001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
    Yan GX; Antzelevitch C
    Circulation; 1999 Oct; 100(15):1660-6. PubMed ID: 10517739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
    Hu D; Viskin S; Oliva A; Carrier T; Cordeiro JM; Barajas-Martinez H; Wu Y; Burashnikov E; Sicouri S; Brugada R; Rosso R; Guerchicoff A; Pollevick GD; Antzelevitch C
    Heart Rhythm; 2007 Aug; 4(8):1072-80. PubMed ID: 17675083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sodium and calcium channel block in unmasking the Brugada syndrome.
    Fish JM; Antzelevitch C
    Heart Rhythm; 2004 Jul; 1(2):210-7. PubMed ID: 15851155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Brugada syndrome. A predicted sudden juvenile death].
    Cau C
    Minerva Med; 1999 Sep; 90(9):359-64. PubMed ID: 10719441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and ionic mechanisms responsible for the Brugada syndrome.
    Antzelevitch C; Yan GX
    J Electrocardiol; 2000; 33 Suppl():33-9. PubMed ID: 11265734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome.
    Noda T; Shimizu W; Taguchi A; Satomi K; Suyama K; Kurita T; Aihara N; Kamakura S
    J Am Coll Cardiol; 2002 Nov; 40(10):1841-7. PubMed ID: 12446069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: current understanding and future challenges in Brugada syndrome.
    Shimizu W; Aiba T; Kamakura S
    Nat Clin Pract Cardiovasc Med; 2005 Aug; 2(8):408-14. PubMed ID: 16119703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brugada-type electrocardiographic pattern induced by epidural bupivacaine.
    Phillips N; Priestley M; Denniss AR; Uther JB
    Anesth Analg; 2003 Jul; 97(1):264-7, table of contents. PubMed ID: 12818979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiogram interpretation and class I blocker challenge in Brugada syndrome.
    Brugada R; Brugada P; Brugada J
    J Electrocardiol; 2006 Oct; 39(4 Suppl):S115-8. PubMed ID: 16934827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brugada syndrome, bupivacaine, lidocaine, and techniques to provide local or regional anesthesia: comments on "Ventricular fibrillation in a patient with a type I Brugada syndrome ECG pattern and hypokalemia"].
    Sánchez Ortega JL; González Pérez P; Escribano Jiménez M
    Rev Esp Anestesiol Reanim; 2008 Oct; 55(8):518-20; author reply 520. PubMed ID: 18985869
    [No Abstract]   [Full Text] [Related]  

  • 16. ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage.
    Shu J; Zhu T; Yang L; Cui C; Yan GX
    J Electrocardiol; 2005 Oct; 38(4 Suppl):26-32. PubMed ID: 16226071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome.
    Szél T; Koncz I; Antzelevitch C
    Heart Rhythm; 2013 Nov; 10(11):1720-7. PubMed ID: 23911896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
    Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
    Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study.
    Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K
    J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.